OB

Otmane Boussif

Chief Technology Officer

Anjarium Biosciences


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Anjarium Biosciences
Industry
biotechnology
Employees
13.0
Seniority
C suite
Annual Revenue
3000000.0
Total Funding
61000000.0
Latest Funding
Series A

Technologies

Outlook CloudFlare Hosting Hubspot Basis Viewpoint

Keywords

drug delivery & gene therapy synthetic dna gene therapy cell therapy dna constructs mrna production aav vector lentiviral vector dna synthesis biologics genetic medicines purity scalability customizable dna r&d solutions high-fidelity double-stranded dna enzymatic synthesis hairpin-ended structures production speed stable polya tail transgene sequences viral titers resin technology chromatography cell-free platform biomanufacturing gmp-certified quality assurance downstream processing research collaboration advanced therapies clinical development innovative methods technical expertise functional applications biomedical research therapeutic modalities contaminant clearance iso9001 compliance commercialization regulatory compliance pharmaceutical development precision medicine investors scientific presentations technical posters next generation therapies healthcare technology biopharmaceutical innovation

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans